The Egyptian Drug Authority (EDA) has issued its first ever guideline on decentralized clinical trials (DCTs), focusing on the benefits and challenges of using off-site or remote nursing services in interventional studies for drugs, biologics and medical devices.
The draft EDA guideline, which is out for public consultation until 25 May, refers to, and builds upon, recent guidelines by the US and EU regulators on DCTs, which allow...